Overview
HUM market data
Price History
HUM price chart · 1M
- O
- 391.48
- H
- 413.24
- L
- 388.98
- C
- 398.16
- Vol
- 155,994.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $391.48
- Previous Close
- $380.23
- Day High
- $413.24
- Day Low
- $388.98
- 52 Week High
- $427.50
- 52 Week Low
- $302.93
- 7 Day Return
- +3.16%
- 30 Day Return
- +1.83%
- 90 Day Return
- +2.27%
- 1 Year Return
- +30.60%
- Daily Notional Volume
- $62.1M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 38.56 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $9.83 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.69 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.7% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $163.11 – $428.88 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $49.3B · P/B 1.74 · P/S 0.34.
Company News
10 captured
The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipientGlobenewswire Inc ·
Can Centene Sustain Its Turnaround Amid Membership Pressure?Zacks Investment Research ·
Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsightGlobenewswire Inc ·
Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?Zacks Investment Research ·
BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?Zacks Investment Research ·